The Journal of Urology
Volume 184, Issue 2 , Pages 743-749 , August 2010

Red Blood Cell Membrane Fragments but Not Intact Red Blood Cells Promote Calcium Oxalate Monohydrate Crystal Growth and Aggregation

  • Somchai Chutipongtanate
    • ,
  • Visith Thongboonkerd

      Affiliations

    • Corresponding Author InformationCorrespondence: Medical Proteomics Unit, Office for Research and Development, Siriraj Hospital, Mahidol University, 12th Floor, Adulyadej Vikrom Building, 2 Prannok Rd., Bangkoknoi, Bangkok 10700, Thailand (telephone and FAX: +66-2-4184793)

Received 23 August 2009

References 

  1. Warpehoski MA, Buscemi PJ, Osborn DC, et al. Distribution of organic matrix in calcium oxalate renal calculi. Calcif Tissue Int. 1981;33:211
  2. Khan SR, Glenton PA, Backov R, et al. Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones. Kidney Int. 2002;62:2062
  3. Ryall RL. Glycosaminoglycans, proteins, and stone formation: adult themes and child's play. Pediatr Nephrol. 1996;10:656
  4. Khan SR, Hackett RL. Role of organic matrix in urinary stone formation: an ultrastructural study of crystal matrix interface of calcium oxalate monohydrate stones. J Urol. 1993;150:239
  5. Lieske JC, Deganello S. Nucleation, adhesion, and internalization of calcium-containing urinary crystals by renal cells. J Am Soc Nephrol. 1999;10(suppl.):S422
  6. Pak CY. Citrate and renal calculi: an update. Miner Electrolyte Metab. 1994;20:371
  7. Nakagawa Y, Ahmed M, Hall SL, et al. Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth (Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid). J Clin Invest. 1987;79:1782
  8. Shiraga H, Min W, VanDusen WJ, et al. Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci USA. 1992;89:426
  9. Ryall RL, Grover PK, Stapleton AM, et al. The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro. Clin Sci (Lond). 1995;89:533
  10. Atmani F, Khan SR. Role of urinary bikunin in the inhibition of calcium oxalate crystallization. J Am Soc Nephrol. 1999;10(suppl.):S385
  11. Chutipongtanate S, Nakagawa Y, Sritippayawan S, et al. Identification of human urinary trefoil factor 1 as a novel calcium oxalate crystal growth inhibitor. J Clin Invest. 2005;115:3613
  12. Parks JH, Coward M, Coe FL. Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int. 1997;51:894
  13. Pak CY. Kidney stones. Lancet. 1998;351:1797
  14. Khan SR, Maslamani SA, Atmani F, et al. Membranes and their constituents as promoters of calcium oxalate crystal formation in human urine. Calcif Tissue Int. 2000;66:90
  15. Fasano JM, Khan SR. Intratubular crystallization of calcium oxalate in the presence of membrane vesicles: an in vitro study. Kidney Int. 2001;59:169
  16. Baggio B, Priante G, Brunati AM, et al. Specific modulatory effect of arachidonic acid on human red blood cell oxalate transport: clinical implications in calcium oxalate nephrolithiasis. J Am Soc Nephrol. 1999;10(suppl.):S381
  17. Messa P, Londero D, Massarino F, et al. Abnormal arachidonic acid content of red blood cell membranes and main lithogenic factors in stone formers. Nephrol Dial Transplant. 2000;15:1388
  18. Kim KM. Mulberry particles formed by red blood cells in human weddelite stones. J Urol. 1983;129:855
  19. Thongboonkerd V, Semangoen T, Chutipongtanate S. Factors determining types and morphologies of calcium oxalate crystals: Molar concentrations, buffering, pH, stirring and temperature. Clin Chim Acta. 2006;367:120
  20. Thongboonkerd V, Chutipongtanate S, Semangoen T, et al. Urinary trefoil factor 1 is a novel potent inhibitor of calcium oxalate crystal growth and aggregation. J Urol. 2008;179:1615
  21. Candiano G, Bruschi M, Musante L, et al. Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis. 2004;25:1327
  22. Nakagawa Y, Abram V, Parks JH, et al. Urine glycoprotein crystal growth inhibitors (Evidence for a molecular abnormality in calcium oxalate nephrolithiasis). J Clin Invest. 1985;76:1455
  23. Tomazic BB, Nancollas GH. The dissolution of calcium oxalate kidney stones (A kinetic study). J Urol. 1982;128:205
  24. Lieske JC, Toback FG, Deganello S. Direct nucleation of calcium oxalate dihydrate crystals onto the surface of living renal epithelial cells in culture. Kidney Int. 1998;54:796
  25. Sheng X, Ward MD, Wesson JA. Crystal surface adhesion explains the pathological activity of calcium oxalate hydrates in kidney stone formation. J Am Soc Nephrol. 2005;16:1904
  26. Schubert G. Stone analysis. Urol Res. 2006;34:146
  27. Stewart GD, Bariol SV, Smith G, et al. Controversial cases in endourology. J Endourol. 2006;20:612
  28. Pereira S, Marwaha RK, Pereira BJ, et al. Haemolytic uraemic syndrome with prolonged anuria and cortical calcification: a case report. Pediatr Nephrol. 1990;4:65

 Supported by Mahidol University, Commission on Higher Education, The Thailand Research Fund, National Center for Genetic Engineering and Biotechnology, and National Research Council of Thailand.

PII: S0022-5347(10)03205-2

doi: 10.1016/j.juro.2010.03.107

The Journal of Urology
Volume 184, Issue 2 , Pages 743-749 , August 2010

Article Tools

* Image Usage & Resolution